Application of Machine Learning to Predict the Risk of Alzheimer's Disease: An Accurate and Practical Solution for Early Diagnostics

• URL: http://arxiv.org/abs/2006.08702v1
• Date: Tue, 2 Jun 2020 14:52:51 GMT
• Title: Application of Machine Learning to Predict the Risk of Alzheimer's Disease: An Accurate and Practical Solution for Early Diagnostics
• Authors: Courtney Cochrane, David Castineira, Nisreen Shiban and Pavlos Protopapas
• Abstract summary: Alzheimer's Disease (AD) ravages the cognitive ability of more than 5 million Americans and creates an enormous strain on the health care system. This paper proposes a machine learning predictive model for AD development without medical imaging and with fewer clinical visits and tests. Our model is trained and validated using demographic, biomarker and cognitive test data from two prominent research studies.
• Score: 1.1470070927586016
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: Alzheimer's Disease (AD) ravages the cognitive ability of more than 5 million Americans and creates an enormous strain on the health care system. This paper proposes a machine learning predictive model for AD development without medical imaging and with fewer clinical visits and tests, in hopes of earlier and cheaper diagnoses. That earlier diagnoses could be critical in the effectiveness of any drug or medical treatment to cure this disease. Our model is trained and validated using demographic, biomarker and cognitive test data from two prominent research studies: Alzheimer's Disease Neuroimaging Initiative (ADNI) and Australian Imaging, Biomarker Lifestyle Flagship Study of Aging (AIBL). We systematically explore different machine learning models, pre-processing methods and feature selection techniques. The most performant model demonstrates greater than 90% accuracy and recall in predicting AD, and the results generalize across sub-studies of ADNI and to the independent AIBL study. We also demonstrate that these results are robust to reducing the number of clinical visits or tests per visit. Using a metaclassification algorithm and longitudinal data analysis we are able to produce a "lean" diagnostic protocol with only 3 tests and 4 clinical visits that can predict Alzheimer's development with 87% accuracy and 79% recall. This novel work can be adapted into a practical early diagnostic tool for predicting the development of Alzheimer's that maximizes accuracy while minimizing the number of necessary diagnostic tests and clinical visits.

Related papers

• A Survey of Models for Cognitive Diagnosis: New Developments and Future Directions [66.40362209055023]
  This paper aims to provide a survey of current models for cognitive diagnosis, with more attention on new developments using machine learning-based methods. By comparing the model structures, parameter estimation algorithms, model evaluation methods and applications, we provide a relatively comprehensive review of the recent trends in cognitive diagnosis models.
  arXiv  Detail & Related papers  (2024-07-07T18:02:00Z)
• A Survey of Artificial Intelligence in Gait-Based Neurodegenerative Disease Diagnosis [51.07114445705692]
  neurodegenerative diseases (NDs) traditionally require extensive healthcare resources and human effort for medical diagnosis and monitoring. As a crucial disease-related motor symptom, human gait can be exploited to characterize different NDs. The current advances in artificial intelligence (AI) models enable automatic gait analysis for NDs identification and classification.
  arXiv  Detail & Related papers  (2024-05-21T06:44:40Z)
• Intelligent Diagnosis of Alzheimer's Disease Based on Machine Learning [24.467566885575998]
  This study is based on the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset. It aims to explore early detection and disease progression in Alzheimer's disease (AD)
  arXiv  Detail & Related papers  (2024-02-13T15:43:30Z)
• A Foundational Framework and Methodology for Personalized Early and Timely Diagnosis [84.6348989654916]
  We propose the first foundational framework for early and timely diagnosis. It builds on decision-theoretic approaches to outline the diagnosis process. It integrates machine learning and statistical methodology for estimating the optimal personalized diagnostic path.
  arXiv  Detail & Related papers  (2023-11-26T14:42:31Z)
• Adapting Machine Learning Diagnostic Models to New Populations Using a Small Amount of Data: Results from Clinical Neuroscience [17.161866044628205]
  We develop a weighted empirical risk minimization approach that optimally combines data from a source group to make predictions on a target group. We apply this method to multi-source data of 15,363 individuals from 20 neuroimaging studies to build ML models for diagnosis of Alzheimer's disease and estimation of brain age.
  arXiv  Detail & Related papers  (2023-08-06T18:05:39Z)
• Deep Reinforcement Learning Framework for Thoracic Diseases Classification via Prior Knowledge Guidance [49.87607548975686]
  The scarcity of labeled data for related diseases poses a huge challenge to an accurate diagnosis. We propose a novel deep reinforcement learning framework, which introduces prior knowledge to direct the learning of diagnostic agents. Our approach's performance was demonstrated using the well-known NIHX-ray 14 and CheXpert datasets.
  arXiv  Detail & Related papers  (2023-06-02T01:46:31Z)
• Incomplete Multimodal Learning for Complex Brain Disorders Prediction [65.95783479249745]
  We propose a new incomplete multimodal data integration approach that employs transformers and generative adversarial networks. We apply our new method to predict cognitive degeneration and disease outcomes using the multimodal imaging genetic data from Alzheimer's Disease Neuroimaging Initiative cohort.
  arXiv  Detail & Related papers  (2023-05-25T16:29:16Z)
• A Comprehensive Study on Machine Learning Methods to Increase the Prediction Accuracy of Classifiers and Reduce the Number of Medical Tests Required to Diagnose Alzheimer'S Disease [0.0]
  The main goal of this study is to fine-tune the classifier to detect illness with fewer tests while maintaining a reasonable disease discovery accuracy. We successfully identified the condition in almost 94% of cases using four of the thirty frequently utilized indicators.
  arXiv  Detail & Related papers  (2022-12-01T10:34:11Z)
• Predicting Alzheimer's Disease Using 3DMgNet [2.97983501982132]
  3DMgNet is a unified framework of multigrid and convolutional neural network to diagnose Alzheimer's disease (AD) The model achieved 92.133% accuracy for AD vs NC classification and significantly reduced the model parameters.
  arXiv  Detail & Related papers  (2022-01-12T09:08:08Z)
• ADiag: Graph Neural Network Based Diagnosis of Alzheimer's Disease [0.0]
  Alzheimer's Disease (AD) is the most widespread neurodegenerative disease, affecting over 50 million people across the world. Currently, only qualitative means of testing are employed in the form of scoring performance on a battery of cognitive tests. We have developed ADiag, a novel quantitative method to diagnose AD through GraphSAGE Network and Dense Differentiable Pooling (DDP) analysis. Preliminary tests of ADiag have revealed a robust accuracy of 83%, vastly outperforming other qualitative and quantitative diagnostic techniques.
  arXiv  Detail & Related papers  (2021-01-08T06:23:30Z)
• Select-ProtoNet: Learning to Select for Few-Shot Disease Subtype Prediction [55.94378672172967]
  We focus on few-shot disease subtype prediction problem, identifying subgroups of similar patients. We introduce meta learning techniques to develop a new model, which can extract the common experience or knowledge from interrelated clinical tasks. Our new model is built upon a carefully designed meta-learner, called Prototypical Network, that is a simple yet effective meta learning machine for few-shot image classification.
  arXiv  Detail & Related papers  (2020-09-02T02:50:30Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.